ONE-WAYOngoing theme · still written in the latest filings
Risks related to patent acquisition, patent terms, and exclusivity for drug candidates
Risk that competitive advantages and future revenue from drug candidates will be impaired because sufficient patent protection cannot be obtained or maintained, patent terms expire, or exclusivity is inadequate.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.